SPRO
Spero Therapeutics Inc
Halal Rating :
Last Price
$0.91
Last updated:
Market Cap
-
7D Change
-4.53%
1 Year Change
-37.08%
Company Overview
Industries
Exchange
Next Earnings Date
Spero Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for bacterial infections and rare diseases. The company's main focus is on developing novel antibiotics to address multidrug-resistant bacterial infections. Their lead product candidates include SPR720 for non-tuberculous mycobacterial infections and SPR206 for multi-drug resistant Gram-negative infections.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $13.47m | $32.06m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $10.2m | $29.26m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $9.27m | $23.25m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Spero Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.